by ilene - April 2nd, 2010 12:01 pm
Déjà vu, all over again.
by ilene - April 2nd, 2010 12:01 pm
Déjà vu, all over again.
October 21st, 2016 12:04 pm
With 'trade' at the center of any substantive differences between US presidential candidates, 1000s protesting 'trade' deals across Europe, 'trade' collapsing in China, and lame-duck Obama trying to push his 'trade' agenda, it is perhaps shocking that Canada’s trade minister walked out of talks to finalize a trade pact with the European Union, saying it now seems the bloc is incapable of reaching such agreements and that Canadian officials are returning home.
As Bloomberg reports, Chrystia Freeland spoke to reporters Friday after negotiations with the European Commission and the leader...
October 21st, 2016 11:07 am
By JOHN F. BANZHAF. Originally published at ValueWalk.
Milo UPDATING EVENT ANNOUNCEMENT – SPEECH AT 5:30 PM
Tonight’s Speech At GWU Provokes National Controversy
Effort to Require His Pledge to Refrain From Hate Speech Rejected
WASHINGTON, D.C. (October 21, 2016): It now appears that the time of the event announced below has been suddenly changed at the last minute to 5:30-6:30 PM from the originally scheduled 7:00-9:00 PM time, although no notification was sent to ticket holders showing the old time, and there was no announcement anywhere else.
Photo by LeWeb14
Thus, for reasons still unknown, it seems that many students eager to hear this controversial speaker will be very disappointed. Also, students are likel...
October 21st, 2016 8:58 am
Financial Markets and Economy
Gold’s best run since 2010 pushed Canadian equities to the top spot among developed-market stocks this year. Fifty dollar crude will give them an opportunity to stay there.
Would Cutting Corporate Tax Rates Really Grow the Economy? (The Atlantic)
One of the things Hillary Clinton and Donald Trump disagree most strongly about is how to stimulate the economy. Donald Trump has one idea that conservative economist...
October 21st, 2016 8:50 am
Courtesy of Chris Kimble.
At one point in time, actually for years, Bio-Tech (IBB) was a market leader. From the 2009 lows to 2015, IBB out gained the S&P by more than 250%. Since the summer of 2015, Bio Tech has remained a leader, a “downside leader!” IBB has lagged the S&P by over 35% in the past 15-months.
Is the downside leadership over for IBB? Below updates the pattern on IBB
CLICK ON CHART TO ENLARGE...
October 20th, 2016 10:32 pm
Courtesy of Mish.
A battle over sanctions is brewing in the EU this evening.
The EU lead by European Council president Donald Tusk seeks more sanctions on Russia over Aleppo.
However, Italian prime minister Matteo Renzi Pushes Back on Sanctions because Italy was stung more by sanctions than other nations.
The European Union said it was too soon to consider imposing sanctions on Russia for the bombing of rebel-held areas of Syria, while maintaining the threat of action if Vladimir Putin doesn’t back down.
After the first of two days of talks in Brussels, EU leaders said “all available options” remain on the table, without mentioning sanc...
October 20th, 2016 8:30 am
Courtesy of Nattering Naybob.A continuation of a Naybob of IT's Natterings from Part 1 and Part 2...
October 20th, 2016 12:00 am
Courtesy of Benzinga.
The fresh food supply chain undergoes a ton of waste. The loss in fresh food nearly costs producers and retailers $160 billion in the US alone. Despite this huge sum, the market to cut down this waste has largely gone unaddressed by corporate America.
Ecoark Holdings Inc (OTC: EARK) is taking steps to address this market and it could ultimately be a win for several parties: the grower, the retailer and the c...
October 18th, 2016 6:57 pm
Courtesy of Declan.Markets were unable to build on premarket gains, but did manage to finish the day where they started.
October 17th, 2016 11:00 am
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...
October 7th, 2016 2:29 pm
Good article on investing success:The Most Overlooked Trait of Investing Success
There is a reason no Berkshire Hathaway investor chides Buffett when the company has a bad quarter. It’s because Buffett has so thoroughly convinced his investors that it’s pointless to try to navigate around 90-day intervals. He’s done that by writing incredibly lucid letters to investors for the last 50 years, communicating in easy-to-understand language at annual meetings, and speaking on TV in ways that someone with no investing experience can grasp.
Yes, Buffett runs an amazing investment company. But he also runs an amazing investor company. One of the most underappreciated part of his s...
September 10th, 2016 5:00 pm
By Jan Skoyles
I was so pleased yesterday by the announcement that I have joined the Research team at GoldCore as it meant that I could finally start talking about it and was back in a role that lets me indulge in my passion by researching and geeking out on all things gold, silver and money.
August 22nd, 2016 1:15 pm
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Epizyme was founded in 2007, and trying to create drugs to treat patient's cancer by focusing on genetically-linked differences between normal and cancer cells. Cancer areas of focus include leukemia, Non-Hodgkin's lymphoma and breast cancer. One of the Epizme cofounders, H. Robert Horvitz, won the Nobel Prize in Medicine in 2002 for "discoveries concerning genetic regulation of organ development and programmed cell death."
Before discussing the drug targets of Epizyme, understanding epigenetics is crucial to comprehend the company's goals.
Genetic components are the DNA sequences that are 'inherited.' Some of these genes are stronger than others in their expression (e.g., eye color). Yet, some genes turn on or off due to external factors (environmental), and it is und...
May 13th, 2016 2:40 pm
Reminder: Harlan is available to chat with Members, comments are found below each post.
December 15th, 2015 2:15 pm
We know you love coming here for our Stocks & Options education, strategy and trade ideas, and for Phil's daily commentary which you can't live without, but there's more!
PhilStockWorld.com features the most important and most interesting news items from around the web, all day, every day!
News: If you missed it, you can probably find it in our Market News section. We sift through piles of news so you don't have to.
If you are looking for non-mainstream, provocatively-narrated news and opinion pieces which promise to make you think -- we feature Zero Hedge, ...
Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...